Beijing Airdoc Technology Co (HKSE:02251) Beneish M-Score: -2.13 (As of Sep. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02251 Beijing Airdoc Technology Co Ltd HKSE:02251
64 GF Score
Price HK$8.01
GF Value HK$15.19
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Beijing Airdoc Technology Co Beneish M-Score?

Beijing Airdoc Technology Co HKSE:02251 +1.39% 64 Beneish M-Score is -2.13 as of Sep. 03, 2026. GuruFocus rates HKSE:02251 with a GF Score™ of 64/100 and a GF Value™ of HK$15.19 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 628 Healthcare Providers & Services companies, Beijing Airdoc Technology Co ranks worse than 77.55% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.13 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Beijing Airdoc Technology Co's Beneish M-Score or its related term are showing as below:

HKSE:02251' s Beneish M-Score Range Over the Past 10 Years
Min: -2.52   Med: -1.79   Max: 2.29
Current: -2.13

During the past 7 years, the highest Beneish M-Score of Beijing Airdoc Technology Co was 2.29. The lowest was -2.52. And the median was -1.79.


Beijing Airdoc Technology Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Beijing Airdoc Technology Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Airdoc Technology Co Beneish M-Score Chart

Beijing Airdoc Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial -1.79 2.29 1.82 -2.52 -2.13

Beijing Airdoc Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.82 0.00 -2.52 0.00 -2.13

HKSE:02251 vs VEEV, BTSG, TEM: Beneish M-Score Comparison

For the Health Information Services subindustry, Beijing Airdoc Technology Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Airdoc Technology Co Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Beijing Airdoc Technology Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Beijing Airdoc Technology Co's Beneish M-Score falls into.


HKSE:02251
64GF Score
Beijing Airdoc Technology Co Ltd HKSE:02251
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Airdoc Technology Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Beijing Airdoc Technology Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1421+0.528 * 0.7506+0.404 * 1.075+0.892 * 1.1465+0.115 * 1.1684
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.4919+4.679 * -0.003346-0.327 * 0.6903
=-2.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was HK$123.3 Mil.
Revenue was HK$191.4 Mil.
Gross Profit was HK$141.4 Mil.
Total Current Assets was HK$875.4 Mil.
Total Assets was HK$1,447.5 Mil.
Property, Plant and Equipment(Net PPE) was HK$22.7 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$22.9 Mil.
Selling, General, & Admin. Expense(SGA) was HK$112.5 Mil.
Total Current Liabilities was HK$83.1 Mil.
Long-Term Debt & Capital Lease Obligation was HK$3.8 Mil.
Net Income was HK$-27.6 Mil.
Gross Profit was HK$0.0 Mil.
Cash Flow from Operations was HK$-22.7 Mil.
Total Receivables was HK$94.1 Mil.
Revenue was HK$166.9 Mil.
Gross Profit was HK$92.5 Mil.
Total Current Assets was HK$954.7 Mil.
Total Assets was HK$1,507.0 Mil.
Property, Plant and Equipment(Net PPE) was HK$20.1 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$28.6 Mil.
Selling, General, & Admin. Expense(SGA) was HK$199.5 Mil.
Total Current Liabilities was HK$130.7 Mil.
Long-Term Debt & Capital Lease Obligation was HK$0.4 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(123.27 / 191.407) / (94.137 / 166.949)
=0.64402 / 0.563867
=1.1421

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(92.542 / 166.949) / (141.362 / 191.407)
=0.554313 / 0.738541
=0.7506

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (875.383 + 22.688) / 1447.545) / (1 - (954.736 + 20.136) / 1506.983)
=0.37959 / 0.353097
=1.075

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=191.407 / 166.949
=1.1465

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(28.611 / (28.611 + 20.136)) / (22.902 / (22.902 + 22.688))
=0.586928 / 0.502347
=1.1684

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(112.473 / 191.407) / (199.451 / 166.949)
=0.587612 / 1.194682
=0.4919

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3.766 + 83.146) / 1447.545) / ((0.404 + 130.673) / 1506.983)
=0.060041 / 0.08698
=0.6903

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-27.591 - 0 - -22.748) / 1447.545
=-0.003346

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Beijing Airdoc Technology Co has a M-score of -2.13 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.13 mean?
Beijing Airdoc Technology Co (HKSE:02251) has a Beneish M-Score of -2.13 as of Sep. 03, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Beijing Airdoc Technology Co and its competitors. According to the industry distribution chart, Beijing Airdoc Technology Co ranks #487 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 77.5%.
Is Beijing Airdoc Technology Co's Beneish M-Score too high?
Beijing Airdoc Technology Co's current Beneish M-Score is -2.13. Based on the distribution chart, Beijing Airdoc Technology Co ranks #487 out of 628 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Beijing Airdoc Technology Co has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Airdoc Technology Co's Beneish M-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Beijing Airdoc Technology Co ranks #487 out of 628 companies for Beneish M-Score. This places Beijing Airdoc Technology Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Beijing Airdoc Technology Co and its competitors. Beijing Airdoc Technology Co's current Beneish M-Score is -2.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Airdoc Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Airdoc Technology Co (HKSE:02251) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$15.19, compared to a current price of HK$8.01 — trading 47.3% below its estimated fair value. The current Beneish M-Score is -2.13. Beijing Airdoc Technology Co's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Beijing Airdoc Technology Co (HKSE:02251), the current Beneish M-Score is -2.13 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Airdoc Technology Co (HKSE:02251) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Airdoc Technology Co stock appears to be undervalued. The current stock price of HK$8.01 is trading 47.3% below its estimated GF Value™ of HK$15.19. GuruFocus considers Beijing Airdoc Technology Co to be Significantly Undervalued.

Key valuation signals for HKSE:02251:

  • Beneish M-Score: -2.13
  • GF Value™: HK$15.19 vs. price of HK$8.01 (47.3% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the HKSE:02251 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Beijing Airdoc Technology Co Business Description

Address West Third Ring North Road, Room 21, 4th Floor, Building 2, A2 Yard, Haidian District, Beijing, CHN, 100089
Beijing Airdoc Technology Co Ltd provides AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions in China. Leveraging retinal imaging, multimodal data analyses, and AI deep learning algorithms, the company's solution differs from traditional chronic disease early detection and diagnosis, enabling non-invasive, accurate, fast, effective, and scalable detection and diagnosis of chronic diseases in both medical institutions and consumer healthcare providers. The Company derives revenue from the provision of AI-based software solutions, sales of hardware devices, and other services. Geographically, the company generates the majority of its revenue from Mainland China.
64GF Score

Get the complete analysis for HKSE:02251

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$8.01
Price
HK$15.19
GF Value